These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38664231)

  • 1. THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma.
    Wang ZH; Wang J; Liu F; Sun S; Zheng Q; Hu X; Yin Z; Xie C; Wang H; Wang T; Zhang S; Wang YP
    FEBS Lett; 2024 Jun; 598(12):1513-1531. PubMed ID: 38664231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
    Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
    Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription.
    Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
    Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
    Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation.
    Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H
    Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
    Fei X; Ma Y; Liu X; Meng Z
    Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.
    Kim JM; Kim K; Schmidt T; Punj V; Tucker H; Rice JC; Ulmer TS; An W
    Nucleic Acids Res; 2015 Oct; 43(18):8868-83. PubMed ID: 26350217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMYD3 regulates the abnormal proliferation of non-small-cell lung cancer cells via the H3K4me3/ANO1 axis.
    Zhong D; Zhan Z; Zhang J; Liu Y; He Z
    J Biosci; 2022; 47():. PubMed ID: 36222132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells].
    Yang L; Ren J; He J; Chen LB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):297-300. PubMed ID: 19403031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
    Chen LB; Xu JY; Yang Z; Wang GB
    World J Gastroenterol; 2007 Nov; 13(43):5718-24. PubMed ID: 17963297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
    Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
    Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.
    Kim H; Heo K; Kim JH; Kim K; Choi J; An W
    J Biol Chem; 2009 Jul; 284(30):19867-77. PubMed ID: 19509295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
    Cock-Rada AM; Medjkane S; Janski N; Yousfi N; Perichon M; Chaussepied M; Chluba J; Langsley G; Weitzman JB
    Cancer Res; 2012 Feb; 72(3):810-20. PubMed ID: 22194464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
    Dai B; Wan W; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2015 Nov; 34(5):2722-30. PubMed ID: 26328527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.